Biotechnology
INTS
3.20
price down icon3.51%   -0.1165
after-market Handel nachbörslich: 3.20

Intensity Therapeutics Inc (INTS)
full-star
loading
Überblick Nachrichten Preisverlauf Financials Warum fällt INTS? Forum Prognose

Warum fällt Intensity Therapeutics Inc-Aktie (INTS)?

Wir haben während der Handelssitzung 2024-10-28 einen Rückgang der Aktie Intensity Therapeutics Inc (INTS) um 5.48% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!
2023-12-14:

Shares of Intensity Therapeutics Inc (INTS) dropped by 18.42% from $9.88 to $8.06 in the trading on Thursday, December 14, 2023. The reason why INTS down today is due to the announcement of a change in board of director. The company announced that Joseph Talamo was appointed as the new CFO, replacing the previous CFO. Investors often pay close attention to change in board of directors, which may have influenced market sentiment and contributed to the decline in INTS's share price.

Ähnlich wie INTS

biotechnology SMMT
$19.96
price up icon 5.11%
biotechnology INCY
$75.75
price down icon 0.50%
biotechnology UTHR
$376.80
price up icon 0.74%
biotechnology MRNA
$53.54
price down icon 2.00%
biotechnology BGNE
$207.25
price up icon 1.49%
biotechnology BNTX
$108.97
price down icon 2.25%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters
Kapitalisierung:     |  Volumen (24h):